Rational design of a cocktail of inhibitors against Aβ aggregation

It has been reported that many molecules could inhibit the aggregation of Abeta (amyloid-beta) through suppressing either primary nucleation, secondary nucleation, or elongation processes. In order to suppress multiple pathways of Abeta aggregation, we screened 23 small molecules and found two types of inhibitors with different inhibiting mechanisms based on chemical kinetics analysis. Trp-glucose conjugates (AS2) could bind with fibril ends while natural products (D3 and D4) could associate with monomers. A cocktail of these two kinds of molecules achieved co-inhibition of various fibrillar species and avoid unwanted interference.